PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$63.95 USD
-0.36 (-0.56%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $63.92 -0.03 (-0.05%) 6:12 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Brokerage Reports
Prestige Consumer Healthcare Inc. [PBH]
Reports for Purchase
Showing records 181 - 200 ( 200 total )
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Household Products/Personal Care: Previewing 3Q16 Earnings
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
No Dramamine Needed for Drug Channel Turbulence; Analysis Shows Little Impact to Sales, EPS
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
NDR with Management Leaves Us Positive on PBH
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Despite Some Particles Stuck in Org. Sales, DenTek Able to Floss Them Out to Deliver Solid Quarter
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Household Products/Personal Care: Previewing 2Q16 Earnings
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
PBH Announces Divestiture of 3 Non-Core OTC Healthcare Brands
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Analyst Day Gives Investors Clear Eyes Toward Solid LT Growth Story
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
4Q Beats Estimates Behind Core Portfolio Strength
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Momentum in Core OTC Portfolio Keeps Us Positive on Story
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Household Products/Personal Care: Will 1Q Results Prove That Defense Really Is the Best Offense?
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
No Prescription Necessary - Conference Call with Investors Maintains Healthy Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Don?t Run to the Doctor, Run to the OTC Counter - Initiating with OW Rating, $60 PT
Provider: KEYBANC CAPITAL MARKETS